A new monoclonal antibody, P2A8(6), that specifically recognizes a novel epitope on the multidrug resistance-associated protein 1 (MRP1), but not on MRP2 nor MRP3

Hybridoma and Hybridomics

Volumn 20, Issue 5-6, 2001, Pages 333-341

  Connolly, L ^a   Moran, Elizabeth ^a   Larkin, A ^a   Scheffer, G ^b   Scheper, R ^b   Sarkadi, B ^c   Kool, M ^d   Clynes, M ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY P2A8(6); MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNIZATION; IMMUNOCYTOCHEMISTRY; LYMPH NODE; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0035744764     PISSN: 15368599     EISSN: None     Source Type: Journal    
DOI: 10.1089/15368590152740734     Document Type: Article

References (44)

1. Recent developments in drug resistance and apoptosis research
2. P-glycoprotein structure and evolutionary homologies. Review
3. The multidrug resistance protein family
4. Biochemistry of multidrug resistance mediated by the multidrug transporter
5. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
6. ABC transporters, from microorganisms to man
7. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP
8. Multidrug resistance in human cancer
9. Expression pattern of MRP in human tissues and adult solid tumour cell lines
10. MRP expression as a predictive marker in multidrug resistant breast cancer
11. The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer
12. Multidrug resistance protein in recurrent breast cancer
13. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump
14. Immunocytochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumour cells by monoclonal antibodies
15. r 190,000 multidrug resistance protein, MRP, with monoclonal antibodies
16. A new mdr-1 encoded P-170 specific monoclonal antibody: (6/1C) on paraffin wax embedded tissue without pretreatment of sections
17. Detection of P-glycoproteinin multi-drug resistant cell line by monoclonal antibodies
18. Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multidrug resistance
19. Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK16
20. Tissue distribution of the multidrug resistance protein
21. Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5 and MDR3 P-glycoprotein with a panel of monoclonal antibodies
22. Location of a protease-hypersensitive region in the multidrug resistance protein (MRP) by mapping of the epitope of MRP-specific monoclonal antibody QCRL-1
23. Epitope mapping of monoclonal antibodies specific for the 190-kDa multidrug resistance protein (MRP)
24. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines
25. Derivation and preliminary characterisation of adriamycin resistant lines of human cancer cells
26. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2
27. MRP3, an organic anion transporter able to transport anti-cancer drugs
28. Cytogenetic comparison of two poorly differentiated human lung squamous cell carcinoma lines
29. Multiple drug resistance in variants of a human non-small-cell lung carcinoma cell line, DLKPA
30. Isolation and characterisation of Adriamycin-resistant HL-60 cells which are not defective in the initial intracellular accumulation of drug
31. Studies of human tumour cell line with a diploid karyotype
32. Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness
33. Expression of the multidrug resistance-associated protein (MRP) and chemoresistance of human non-small-cell lung cancer cells
34. Continuos cultures of fused cells secreting antibody of predefined specificity
35. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
36. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedures and some applications
37. P-glycoprotein in human sarcoma: Evidence for multidrug resistance
38. Investigations of multidrug resistance (MDR) protein levels in pre- and post-treatment samples from breast cancer patients
39. Use of avidin-biotin-peroxidas e complex (ABC) in immunoperoxidase techniques
40. A new monoclonal antibody that specifically recognises the MDR-3-encoded gene product
41. Membrane topology and glycosylation of the human multidrug resistance-associated protein
42. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein
43. The expression of multidrug resistance protein in human gastrointestinal tract carcinomas